On risk and plant-based biopharmaceuticals

Robert K D Peterson, Charles J. Arntzen

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Research into plant-based expression of pharmaceutical proteins is proceeding at a blistering pace. Indeed, plants expressing pharmaceutical proteins are currently being grown in field environments throughout the USA. But how are these plants and proteins being assessed for environmental risk and how are they being regulated? Here, we examine the applicability of the risk assessment paradigm for assessing human and ecological risks from field-grown transgenic plants that express pharmaceutical proteins.

Original languageEnglish (US)
Pages (from-to)64-66
Number of pages3
JournalTrends in Biotechnology
Volume22
Issue number2
DOIs
StatePublished - Feb 2004

Fingerprint

Proteins
Drug products plants
Drug products
Plant Proteins
Genetically Modified Plants
Medicinal Plants
Pharmaceutical Preparations
Risk assessment
Research

ASJC Scopus subject areas

  • Bioengineering

Cite this

On risk and plant-based biopharmaceuticals. / Peterson, Robert K D; Arntzen, Charles J.

In: Trends in Biotechnology, Vol. 22, No. 2, 02.2004, p. 64-66.

Research output: Contribution to journalArticle

Peterson, Robert K D ; Arntzen, Charles J. / On risk and plant-based biopharmaceuticals. In: Trends in Biotechnology. 2004 ; Vol. 22, No. 2. pp. 64-66.
@article{a04e3cd9a2bd4e89b3b1fb321be96e28,
title = "On risk and plant-based biopharmaceuticals",
abstract = "Research into plant-based expression of pharmaceutical proteins is proceeding at a blistering pace. Indeed, plants expressing pharmaceutical proteins are currently being grown in field environments throughout the USA. But how are these plants and proteins being assessed for environmental risk and how are they being regulated? Here, we examine the applicability of the risk assessment paradigm for assessing human and ecological risks from field-grown transgenic plants that express pharmaceutical proteins.",
author = "Peterson, {Robert K D} and Arntzen, {Charles J.}",
year = "2004",
month = "2",
doi = "10.1016/j.tibtech.2003.11.007",
language = "English (US)",
volume = "22",
pages = "64--66",
journal = "Trends in Biotechnology",
issn = "0167-7799",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - On risk and plant-based biopharmaceuticals

AU - Peterson, Robert K D

AU - Arntzen, Charles J.

PY - 2004/2

Y1 - 2004/2

N2 - Research into plant-based expression of pharmaceutical proteins is proceeding at a blistering pace. Indeed, plants expressing pharmaceutical proteins are currently being grown in field environments throughout the USA. But how are these plants and proteins being assessed for environmental risk and how are they being regulated? Here, we examine the applicability of the risk assessment paradigm for assessing human and ecological risks from field-grown transgenic plants that express pharmaceutical proteins.

AB - Research into plant-based expression of pharmaceutical proteins is proceeding at a blistering pace. Indeed, plants expressing pharmaceutical proteins are currently being grown in field environments throughout the USA. But how are these plants and proteins being assessed for environmental risk and how are they being regulated? Here, we examine the applicability of the risk assessment paradigm for assessing human and ecological risks from field-grown transgenic plants that express pharmaceutical proteins.

UR - http://www.scopus.com/inward/record.url?scp=1642563969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642563969&partnerID=8YFLogxK

U2 - 10.1016/j.tibtech.2003.11.007

DO - 10.1016/j.tibtech.2003.11.007

M3 - Article

VL - 22

SP - 64

EP - 66

JO - Trends in Biotechnology

JF - Trends in Biotechnology

SN - 0167-7799

IS - 2

ER -